Literature DB >> 8435092

Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis.

E T Morgan1.   

Abstract

Inflammatory stimuli suppress constitutive hepatic expression of the CYP2C11 and CYP2C12 genes in male and female rat livers, respectively. Because growth hormone (GH) is an important regulator of P450 gene expression in the rat, the effects of bacterial endotoxin injection in hypophysectomized rats were compared to those in normal animals. In intact females, 0.2 mg/kg endotoxin suppressed total P450 and hepatic expression of CYP2C6, CYP2C7, CYP2C12, and CYP2E1 mRNAs, as well as CYP2C12 and CYP2E1 proteins, measured 16 hr later. CYP2C7 and CYP2E1 mRNAs were most affected (17 and 13% of untreated levels, respectively). Endotoxin treatment also induced the mRNA for the hepatic acute phase protein, haptoglobin, to 260% of control female levels. In hypophysectomized females supplemented with GH infusion, endotoxin caused the same or greater effects on expression of the P450 and haptoglobin gene products than were observed in the intact animals. It is concluded that the P450 suppression observed after endotoxin administration can occur independently of an effect on pituitary hormone secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435092     DOI: 10.1016/0006-2952(93)90078-b

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse.

Authors:  P C Mills; J C Ng; D E Auer
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

3.  Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin.

Authors:  Ragini Vuppugalla; Rakhi B Shah; Anjaneya P Chimalakonda; Charles W Fisher; Reza Mehvar
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

4.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants.

Authors:  O G Khatsenko; S S Gross; A B Rifkind; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

5.  Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/reperfusion.

Authors:  Hyun-Ae Eum; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

6.  Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.

Authors:  Madhusudana R Chaluvadi; Ryan D Kinloch; Beatrice A Nyagode; Terrilyn A Richardson; Malik J Raynor; Melanie Sherman; Leposava Antonovic; Henry W Strobel; Dirck L Dillehay; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-10-29       Impact factor: 3.922

7.  Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.

Authors:  S I Shedlofsky; B C Israel; C J McClain; D B Hill; R A Blouin
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.

Authors:  Qichao Huang; Biaoyang Lin; Hanqiang Liu; Xi Ma; Fan Mo; Wei Yu; Lisha Li; Hongwei Li; Tian Tian; Dong Wu; Feng Shen; Jinliang Xing; Zhi-Nan Chen
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

9.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

10.  The effects of agomelatine and imipramine on liver cytochrome P450 during chronic mild stress (CMS) in the rat.

Authors:  Anna Haduch; Ewa Bromek; Marta Rysz; Renata Pukło; Mariusz Papp; Piotr Gruca; Magdalena Łasoń; Monika Niemczyk; Władysława A Daniel
Journal:  Pharmacol Rep       Date:  2020-08-03       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.